Prevalence of Masked Hypertension in Nephrological Patients

October 27, 2021 updated by: Waid City Hospital, Zurich
The purpose of this study is to determine the percentage of patients with masked hypertension in a population with chronic kidney disease. The investigators goal is to register prospectively ambulatory blood pressure measurement results of patients of a nephrological outpatient clinic with normal office blood pressure to finally find the percentage of masked hypertension in this population.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Zurich, Switzerland, 8037
        • Recruiting
        • Stadtspital Waid Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with chronic kidney disease of the nephrological outpatient clinic of Waidspital with normal office blood pressure in the context of diagnosed arterial hypertension with or without antihypertensive medication

Description

Inclusion Criteria:

  • Age: 20-90 years
  • Known arterial hypertension and antihypertensive medical treatment
  • Office blood pressure < 140 mmHg systolic and <90 mmHg diastolic

Exclusion Criteria:

  • Age <20 or >90 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CKD patients
Patients with chronic kidney disease, with diagnosed arterial hypertension and normal blood pressure during office blood pressure measurement. Comparison of ambulatory blood pressure (ABPM) with office blood pressure measurements (OBPM).
No interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of participants with uncontrolled masked hypertension assessed by comparison of ambulatory blood pressure with office blood pressure
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andreas Schleich, Stadtspital Waid Zurich Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (ANTICIPATED)

January 1, 2023

Study Completion (ANTICIPATED)

November 1, 2023

Study Registration Dates

First Submitted

January 18, 2016

First Submitted That Met QC Criteria

January 21, 2016

First Posted (ESTIMATE)

January 26, 2016

Study Record Updates

Last Update Posted (ACTUAL)

October 28, 2021

Last Update Submitted That Met QC Criteria

October 27, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • WaidBP16

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Masked Hypertension

Clinical Trials on Comparison ABPM with OBPM

Subscribe